mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.2 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.2 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |